Episode Details
Back to Episodes
New FDA SaMD Guidance Will Bring Monumental Changes to Industry
Published 2 years, 7 months ago
Description
David Klein, co founder and CEO of Click Therapeutics, discusses the new FDA SaMD guidance, the clear differences between companion apps and SaMD, and gives insight into what to expect from this combination in the future.